Literature DB >> 20852010

Is discussion of colorectal cancer screening options associated with heightened patient confusion?

Resa M Jones1, Sally W Vernon, Steven H Woolf.   

Abstract

BACKGROUND: Clinical guidelines recommend offering patients options for colorectal cancer (CRC) screening, but the modalities vary by frequency, accuracy, preparations, discomfort, and cost, which may cause confusion and reduce screening rates. We examined whether patients reported confusion about the options and whether confusion was associated with socio-demographic characteristics, number of options discussed, and adherence.
METHODS: Patients ages 50 to 75 years who had visited a clinician within 2 years were randomly selected for a cross-sectional study (n = 6,100). A questionnaire mailed in 2007 asked the following: whether a clinician had ever discussed CRC screening options; which of four recommended tests (i.e., fecal occult blood testing, flexible sigmoidoscopy, colonoscopy, and barium enema) were presented; and whether the options were confusing. Analyses were restricted to respondents who reported discussing one or more screening options (n = 1,707). Weighted frequencies were calculated and multivariate logistic regression was done.
RESULTS: The sample was 55.5% female, 15.6% African American, and 83.2% adherent to screening recommendations, and 56.0% had discussed two or more screening options. In adjusted analyses, nonadherent patients reported greater confusion than adherent patients (P < 0.01). Adults who discussed two or more options were 1.6 times more likely to be confused than those who discussed one option [95% confidence interval (CI), 1.08-2.26]. Patients who reported being confused were 1.8 times more likely to be nonadherent to screening than those who did not (95% CI, 1.14-2.75).
CONCLUSIONS: Our study provides the first empirical evidence linking multiple options with confusion and confusion with screening adherence. IMPACT: Confusion may act as a barrier to screening and should be considered in public health messages and interventions. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20852010      PMCID: PMC2976781          DOI: 10.1158/1055-9965.EPI-10-0695

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  The best screening test for colorectal cancer--a personal choice.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

Authors:  Sally W Vernon; Helen Meissner; Carrie Klabunde; Barbara K Rimer; Dennis J Ahnen; Roshan Bastani; Margaret T Mandelson; Marion R Nadel; Sherri Sheinfeld-Gorin; Jane Zapka
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

3.  Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults.

Authors:  Carrie N Klabunde; Sally W Vernon; Marion R Nadel; Nancy Breen; Laura C Seeff; Martin L Brown
Journal:  Med Care       Date:  2005-09       Impact factor: 2.983

4.  Screening for colorectal cancer: the glass is half full.

Authors:  Alfred I Neugut; Benjamin Lebwohl
Journal:  Am J Public Health       Date:  2009-01-15       Impact factor: 9.308

5.  Patient-physician colorectal cancer screening discussions and screening use.

Authors:  Jennifer Elston Lafata; George Divine; Christina Moon; L Keoki Williams
Journal:  Am J Prev Med       Date:  2006-07-24       Impact factor: 5.043

Review 6.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

7.  Use of colorectal cancer tests--United States, 2002, 2004, and 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-03-14       Impact factor: 17.586

8.  Patterns of colorectal cancer screening uptake among men and women in the United States.

Authors:  Helen I Meissner; Nancy Breen; Carrie N Klabunde; Sally W Vernon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

9.  Effect of incentives and mailing features on online health program enrollment.

Authors:  Gwen L Alexander; George W Divine; Mick P Couper; Jennifer B McClure; Melanie A Stopponi; Kristine K Fortman; Dennis D Tolsma; Victor J Strecher; Christine Cole Johnson
Journal:  Am J Prev Med       Date:  2008-05       Impact factor: 5.043

10.  Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.

Authors:  Sarah T Hawley; Robert J Volk; Partha Krishnamurthy; Maria Jibaja-Weiss; Sally W Vernon; Suzanne Kneuper
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

View more
  14 in total

1.  Physician use of persuasion and colorectal cancer screening.

Authors:  Jennifer Elston Lafata; Tracy Wunderlich; Susan A Flocke; Nancy Oja-Tebbe; Karen E Dyer; Laura A Siminoff
Journal:  Transl Behav Med       Date:  2015-03       Impact factor: 3.046

2.  Effects of an entertaining, culturally targeted narrative and an appealing expert interview on the colorectal screening intentions of African American women.

Authors:  May G Kennedy; Donna McClish; Resa M Jones; Yan Jin; Diane B Wilson; Diane L Bishop
Journal:  J Community Psychol       Date:  2018-04-27

3.  From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society.

Authors:  Robert J Volk; Viola B Leal; Lianne E Jacobs; Andrew M D Wolf; Durado D Brooks; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

4.  Patient-provider discussions about colorectal cancer screening: who initiates elements of informed decision making?

Authors:  Mira L Katz; Ben Broder-Oldach; James L Fisher; Justin King; Kathy Eubanks; Kelly Fleming; Electra D Paskett
Journal:  J Gen Intern Med       Date:  2012-04-05       Impact factor: 5.128

5.  Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer?

Authors:  Karen Bronner; Ilse Mesters; Ahuva Weiss-Meilnik; Ravit Geva; Guy Rozner; Hana Strul; Moshe Inbar; Zamir Halpern; Revital Kariv
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

6.  Risk assessment and clinical decision making for colorectal cancer screening.

Authors:  Paul C Schroy; Sarah E Caron; Bonnie J Sherman; Timothy C Heeren; Tracy A Battaglia
Journal:  Health Expect       Date:  2013-07-30       Impact factor: 3.377

7.  Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making.

Authors:  Paul C Schroy; Shamini Mylvaganam; Peter Davidson
Journal:  Health Expect       Date:  2011-09-08       Impact factor: 3.377

8.  The effects of test preference, test access, and navigation on colorectal cancer screening.

Authors:  Constantine Daskalakis; Sally W Vernon; Randa Sifri; Melissa DiCarlo; James Cocroft; Jocelyn Andrel Sendecki; Ronald E Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-09       Impact factor: 4.254

Review 9.  Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review.

Authors:  Erica G Bromley; Folasade P May; Lisa Federer; Brennan M R Spiegel; Martijn G H van Oijen
Journal:  Prev Med       Date:  2014-12-04       Impact factor: 4.018

10.  Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults.

Authors:  Adeyinka O Laiyemo; Akeem O Adebogun; Chyke A Doubeni; Luisel Ricks-Santi; Shelly McDonald-Pinkett; Patrick E Young; Brooks D Cash; Carrie N Klabunde
Journal:  Prev Med       Date:  2014-06-23       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.